ArticleInternational journal of women's health2026
Blood Count-Derived Inflammatory Indices at Two Timepoints in Insulin-Treated Gestational Diabetes: A Retrospective Cohort Study.
Article in International journal of women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Complete blood count-derived inflammatory indices are widely studied in pregnancy, with inconsistent findings; if they capture a persistent maternal characteristic, a woman's value at one timepoint should locate her value at another. We examined within-woman tracking of six indices, and their relation to fetal overgrowth, in insulin-treated gestational diabetes (GDM). Patients and Methods: Retrospective cohort of 358 women with insulin-treated GDM at a tertiary centre. Six indices (NLR, PLR, MLR, SII, SIRI, PIV) were calculated at the oral glucose tolerance test (OGTT, 24-28 weeks) and at delivery admission, two physiologically distinct occasions. The primary outcome was large-for-gestational-age (LGA) birth (INTERGROWTH-21st); macrosomia was secondary. Tracking was quantified by Spearman correlation and the between-woman variance share from a mixed model. Analytic samples were 358 (group comparisons, discrimination), 353 (paired) and 284 (adjusted models), one lower in each for MLR, SIRI and PIV. Results: LGA occurred in 139 infants (38.8%). No index discriminated LGA to a clinically useful degree (AUC 0.51-0.57). Adjusted for body-mass index (BMI) and HbA1c, SIRI was associated with LGA (OR 1.64 per standard deviation, 95% CI 1.18-2.39; n = 283) and survived Bonferroni correction (corrected P = 0.040), though not consistently across samples; we regard this nominal finding as exploratory. BMI and HbA1c, per standard deviation, had odds ratios of 1.42 and 1.48 and numerically higher AUCs (0.63 each). All six indices changed between the two occasions (all P<0.001); within-woman rank correlation was weak to moderate (ρ 0.27-0.54) and the between-woman variance share 0.25-0.56. Conclusion: CBC-derived indices tracked poorly within women between the two occasions, and none discriminated LGA to a clinically useful degree. Whether this reflects instability of the underlying inflammatory state or the differing clinical circumstances of the two samples cannot be determined from this design.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.